Analysed Spyre Therapeutics Inc (SYRE:NASDAQ) News Sources
Spyre Therapeutics, Inc.: Spyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
FinanzNachrichten.de
Spyre Therapeutics Stock Surges This Past Year as $10.5 Million Buy Lifts Stake to $78 Million
Yahoo Finance
Spyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Yahoo Finance Canada
Spyre Therapeutics Announces Presentations at the 21st ECCO Congress Supporting Differentiated Profile of SPY003 and Novel Animal Studies Demonstrating Superiority of ...
Yahoo Finance UK
Analysts Offer Insights on Healthcare Companies: Integer Holdings (ITGR), Spyre Therapeutics (SYRE) and Tandem Diabetes Care (TNDM)
The Globe and Mail
What is the current price of Spyre Therapeutics Inc (SYRE:NASDAQ)?
The current price of Spyre Therapeutics Inc (SYRE:NASDAQ) is $43.88.
Spyre Therapeutics Inc (SYRE:NASDAQ) absolute price change since previous trading day?
The absolute price change of Spyre Therapeutics Inc (SYRE:NASDAQ) since the previous trading day is $0.43.
Spyre Therapeutics Inc (SYRE:NASDAQ) percentage price change since previous trading day?
The percentage price change of Spyre Therapeutics Inc (SYRE:NASDAQ) since the previous trading day is 0.99%.
What is This Week's average sentiment score for Spyre Therapeutics Inc (SYRE:NASDAQ)?
This Week's average sentiment score for Spyre Therapeutics Inc (SYRE:NASDAQ) is 85 out of 100.
What is This Week's average sentiment for Spyre Therapeutics Inc (SYRE:NASDAQ)?
This Week's sentiment for Spyre Therapeutics Inc (SYRE:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.